Evidence map›Paper›PMID 42684610›Full record

ArticleMolecular biology reports2026

STAT3-mediated suppression of the pre-induction silencer Ets-2 in activated T helper cells.

Vasiliki Theodoraki, Charalampos Lazaris, Athanasia Mouzaki, Tassos Georgakopoulos

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vasiliki TheodorakiLaboratory of Immunohematology, Medical School, University of Patras, GR-26500, Patras, Greece.
Charalampos LazarisLaura and Isaac Perlmutter Cancer Center and Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU School of Medicine, New York, NY, USA.
Athanasia MouzakiLaboratory of Immunohematology, Medical School, University of Patras, GR-26500, Patras, Greece. mouzaki@upatras.gr.ORCID https://orcid.org/0000-0001-5548-7002
Tassos GeorgakopoulosLaboratory of Immunohematology, Medical School, University of Patras, GR-26500, Patras, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterleukin-2 (IL-2) is the first cytokine produced by naive T helper (Th) cells after antigen recognition and is essential for initiating Th cell proliferation and differentiation. We previously identified the transcription factor Ets-2 as a pre-induction silencer of IL-2, showing that its downregulation upon Th cell activation permits IL-2 transcription. However, the upstream mechanisms regulating Ets-2 expression remain undefined. Given the central role of STAT family transcription factors in Th cell gene regulation, we investigated whether STAT signaling controls Ets-2 transcription. METHODS AND

resultsBioinformatic analysis identified STAT binding motifs within the Ets-2 promoter. Using the Jurkat T cell line as a model, we examined changes in STAT3, Ets-2, and IL-2 expression following cell activation. STAT3 function was assessed through overexpression and knockdown experiments, with Ets-2 mRNA and protein levels measured by real-time PCR and western blotting. Chromatin immunoprecipitation was used to determine direct binding of STAT3 to the Ets-2 promoter. Our results showed that cell activation led to increased STAT3 mRNA and protein expression, accompanied by reduced Ets-2 expression and enhanced IL-2 production. STAT3 overexpression significantly decreased Ets-2 mRNA and protein levels, whereas STAT3 knockdown resulted in increased Ets-2 expression. Chromatin immunoprecipitation demonstrated direct binding of phosphorylated STAT3 (Tyr705) to the Ets-2 promoter.

conclusionsSTAT3 acts as a negative regulator of Ets-2 transcription in Th cells through direct binding in its phosphorylated form to the Ets-2 promoter, establishing a causal suppressive pathway linking STAT3 activation to IL-2 de-repression.

Indexed as

Proto-Oncogene Protein c-ets-2STAT3 Transcription FactorT-Lymphocytes, Helper-InducerCell DifferentiationGene Expression RegulationHumansInterleukin-2Jurkat CellsLymphocyte ActivationPromoter Regions, GeneticSignal TransductionETS2 protein, humanInterleukin-2Proto-Oncogene Protein c-ets-2STAT3 protein, humanSTAT3 Transcription FactorEts-2IL-2STAT3T helper cellsTranscription factors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.